Some Gliflozin Side Effects Worse in Autoimmune Rheumatic Disease Something to consider when prescribing SGLT-2 inhibitors Nov 14, 2023
AMA Supports Tighter Restrictions to Curb Pollution From Industrialized Farms Concentrated Animal Feeding Operations "may be a public health hazard," group says Nov 14, 2023
Tirzepatide Wins FDA Approval for Weight Loss Drug also gets a new brand name, Zepbound, for its new indication Nov 08, 2023
Hospitalizations After Fake Ozempic; Abortion Rights Win Big; Ketamine Use Booms Health news and commentary from around the Web gathered by Ƶ staff Nov 08, 2023
Kidney Week Roundup: Cell Therapy Cuts Immunosuppressive Drug Use Post-Transplant Plus: bardoxolone methyl for diabetic kidney disease and spironolactone in hemodialysis patients Nov 07, 2023
Tone Matters in Weight-Loss Talks; Salt and Diabetes; Nix Brominated Veg Oil? News and commentary from the endocrinology world Nov 07, 2023
Novel Aldosterone Synthase Inhibitor Cuts Albuminuria in Phase II Trial Trial tested BI 690517 with and without empagliflozin Nov 06, 2023
Gene Therapy Controls Diabetic Eye Disease for at Least a Year All but one patient with nonproliferative diabetic retinopathy had stable disease or improvement Nov 06, 2023
Eye Drops Make Bid for Role in Diabetic Macular Edema Improved visual acuity, retinal thickness at 6 and 12 weeks, but treatment burden questioned Nov 05, 2023
ERA and SGLT2 Inhibitor Combo Cuts Albuminuria in Chronic Kidney Disease But ZENITH-CKD trial had to pivot to only using low-dose zibotentan due to fluid retention Nov 05, 2023
Heat and Cardiovascular Death; Time-Restricted Eating or Caloric Restriction in T2D Also in TTHealthWatch: managing nasal airway obstruction Nov 04, 2023 podcast
Year in Review: Type 2 Diabetes New approvals, guidance on GLP-1s before surgery, and access issues led the news in 2023 Nov 01, 2023
Intermittent Fasting for T2D; Omnipod 5 App Cleared; GLP-1 Meds and Thyroid Cancer News and commentary from the endocrinology world Oct 31, 2023
Wegovy and Thyroid Cancer; Maine Shooter's Mental Health; 469 Heat Deaths Health news and commentary from around the Web gathered by Ƶ staff Oct 30, 2023
Diabetic Eye Screening: Reducing Frequency May Raise Retinal Risks Switching from annual to biennial exams would delay diabetic retinopathy diagnoses, study shows Oct 27, 2023
Another Study Highlights Metformin's Dementia Protection Properties Association appeared irrespective of HbA1c level Oct 25, 2023
Hospitalizations With Fake Ozempic; Vosoritide OK'd for All Ages; Mounjaro for Kids? News and commentary from the endocrinology world Oct 24, 2023
Counterfeit Ozempic; Mary Lou Retton Discharged; No Such Thing as Free Will? Health news and commentary from around the Web gathered by Ƶ staff Oct 24, 2023
CVS Pulls Phenylephrine Cold Meds; Doc's Murder/Suicide; Red Meat and Diabetes Health news and commentary from around the Web gathered by Ƶ staff Oct 20, 2023
Highly Potent Statin Stands Out for Diabetes, Cataract Risks Head-to-head comparison of rosuvastatin vs atorvastatin in LODESTAR trial Oct 19, 2023
Gestational Diabetes Exposure in Utero Linked to Brain Changes in Kids These changes may contribute to an increased risk of obesity in kids, researcher says Oct 18, 2023
Tirzepatide Has Huge Impact on Weight, Even After Loss From Lifestyle Change Trial participants lost over a fifth of their body weight atop diet, exercise-induced losses Oct 16, 2023
Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Test News and commentary from the endocrinology world Oct 10, 2023
Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Says Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
Inflammation of the Aorta; Afib in the Hospital Also in TTHealthWatch: standards for osteoporosis screening and HbA1c in premenopausal women Oct 07, 2023 podcast
CPAP Turns in Mixed Results for Patients With Diabetic Eye Disease Slower progression of retinal disease, but an increase in microhemorrhages Oct 06, 2023
Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Risk Those with the most metabolic changes, genetic risk had a threefold higher diabetes risk Oct 06, 2023
Faster-Acting Insulin Aspart Safe for Pregnant Women With Diabetes The faster formulation led to fewer hypoglycemia events versus conventional insulin aspart Oct 06, 2023
Mixed Bag for Early Metformin in Gestational Diabetes EMERGE trial misses on primary endpoint, but secondary outcomes suggest potential benefit Oct 03, 2023
Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2D Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
Pharmacists Improve Diabetes Control for Hispanic Patients Medication-adjustment recommendations were linked to some improvements in type 2 diabetes Oct 02, 2023
MedPod Today: Big Medical Bill; GLP-1 Agonist Plateau; Grateful Patient Fundraising Ƶ reporters offer further insights on these recently covered topics Sep 29, 2023 podcast
New Insight Into Hyperglycemia Risk With PI3K Inhibitor for Breast Cancer Significantly more common in community setting, predicted by high baseline HbA1c Sep 28, 2023
FDA Adds Intestinal Blockage Reports to Ozempic Labeling Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
Postmenopausal Fracture Risk for SGLT2 Inhibitors Similar to Other Diabetes Drugs Lower risk compared with DPP-4 inhibitors, and similar risk versus GLP-1 receptor agonists Sep 26, 2023
Record-Breaking Obesity Certifications; 365-Day CGM Data; Med Spa Mounjaro Lawsuits News and commentary from the endocrinology world Sep 26, 2023
AI System Outperforms Standard Review of Imaging for Retinal Disease Offers potential to reduce current manual grading workload Sep 25, 2023
The GLP-1 Agonist Plateau No One's Talking About Weight stabilization is no surprise to specialists, but for patients it's more complicated Sep 22, 2023
FDA Approves Another SGLT2 Inhibitor for Treating CKD Empagliflozin adds indication in adults, regardless of diabetes status Sep 22, 2023
FDA Panel: All Thumbs Down for GLP-1 Agonist Implant for Diabetes We haven't seen "the best version of this device," said panel member Sep 22, 2023
